Department of Cell Biology, Federal University of Paraná, Curitiba, Paraná, Brazil.
J Cell Biochem. 2013 Nov;114(11):2479-92. doi: 10.1002/jcb.24594.
Brown spider (Loxosceles genus) bites have been reported worldwide. The venom contains a complex composition of several toxins, including phospholipases-D. Native or recombinant phospholipase-D toxins induce cutaneous and systemic loxoscelism, particularly necrotic lesions, inflammatory response, renal failure, and hematological disturbances. Herein, we describe the cloning, heterologous expression and purification of a novel phospholipase-D toxin, LiRecDT7 in reference to six other previously described in phospholipase-D toxin family. The complete cDNA sequence of this novel brown spider phospholipase-D isoform was obtained and the calculated molecular mass of the predicted mature protein is 34.4 kDa. Similarity analyses revealed that LiRecDT7 is homologous to the other dermonecrotic toxin family members particularly to LiRecDT6, sharing 71% sequence identity. LiRecDT7 possesses the conserved amino acid residues involved in catalysis except for a conservative mutation (D233E) in the catalytic site. Purified LiRecDT7 was detected as a soluble 36 kDa protein using anti-whole venom and anti-LiRecDT1 sera, indicating immunological cross-reactivity and evidencing sequence-epitopes identities similar to those of other phospholipase-D family members. Also, LiRecDT7 exhibits sphingomyelinase activity in a concentration dependent-manner and induces experimental skin lesions with swelling, erythema and dermonecrosis. In addition, LiRecDT7 induced a massive inflammatory response in rabbit skin dermis, which is a hallmark of brown spider venom phospholipase-D toxins. Moreover, LiRecDT7 induced in vitro hemolysis in human erythrocytes and increased blood vessel permeability. These features suggest that this novel member of the brown spider venom phospholipase-D family, which naturally contains a mutation (D233E) in the catalytic site, could be useful for future structural and functional studies concerning loxoscelism and lipid biochemistry.
1- Novel brown spider phospholipase-D recombinant toxin contains a conservative mutation (D233E) on the catalytic site. 2-LiRecDT7 shares high identity level with isoforms of Loxosceles genus. 3-LiRecDT7 is a recombinant protein immunodetected by specific antibodies to native and recombinant phospholipase-D toxins. 4-LiRecDT7 shows sphingomyelinase-D activity in a concentration-dependent manner, but less intense than other isoforms. 5-LiRecDT7 induces dermonecrosis and inflammatory response in rabbit skin. 6-LiRecDT7 increases vascular permeability in mice. 7-LiRecDT7 triggers direct complement-independent hemolysis in erythrocytes.
已在全球范围内报告了棕色蜘蛛(Loxosceles 属)咬伤事件。该毒液含有多种毒素的复杂成分,包括磷脂酶-D。天然或重组的磷脂酶-D 毒素会引起皮肤和全身的类狼蛛病,特别是坏死性病变、炎症反应、肾衰竭和血液学紊乱。在此,我们描述了一种新型的磷脂酶-D 毒素 LiRecDT7 的克隆、异源表达和纯化,该毒素与之前描述的其他 6 种磷脂酶-D 毒素家族成员有关。该新型棕色蜘蛛磷脂酶-D 同工型的完整 cDNA 序列已获得,预测成熟蛋白的计算分子质量为 34.4 kDa。相似性分析表明,LiRecDT7 与其他真皮坏死毒素家族成员具有同源性,特别是与 LiRecDT6 具有 71%的序列同一性。LiRecDT7 具有参与催化的保守氨基酸残基,除催化位点的保守突变(D233E)外。使用抗全毒液和抗 LiRecDT1 血清检测到纯化的 LiRecDT7 为可溶性 36 kDa 蛋白,表明免疫交叉反应,并证明与其他磷脂酶-D 家族成员具有相似的序列表位身份。此外,LiRecDT7 以浓度依赖的方式表现出神经鞘磷脂酶活性,并诱导肿胀、红斑和真皮坏死的实验性皮肤病变。此外,LiRecDT7 在兔皮真皮中诱导大量炎症反应,这是棕色蜘蛛毒液磷脂酶-D 毒素的一个标志。此外,LiRecDT7 在体外诱导人红细胞溶血,并增加血管通透性。这些特征表明,这种新型的棕色蜘蛛毒液磷脂酶-D 家族成员自然含有催化位点的突变(D233E),可用于未来有关类狼蛛病和脂质生物化学的结构和功能研究。
1-新型棕色蜘蛛磷脂酶-D 重组毒素在催化位点含有保守突变(D233E)。2-LiRecDT7 与 Loxosceles 属的同工型具有高同源性。3-LiRecDT7 是一种重组蛋白,可被针对天然和重组磷脂酶-D 毒素的特异性抗体免疫检测到。4-LiRecDT7 以浓度依赖的方式表现出神经鞘磷脂酶-D 活性,但强度低于其他同工型。5-LiRecDT7 在兔皮中诱导真皮坏死和炎症反应。6-LiRecDT7 增加小鼠血管通透性。7-LiRecDT7 引发红细胞直接补体非依赖性溶血。